BALTIMORE, Md. (November 7, 2018) — Sebastian Seiguer, CEO of emocha Mobile Health Inc., issued the following statement in response to the Centers for Medicare & Medicaid Services’ (CMS) final policy, payment, and quality provisions changes to the Medicare Physician Fee Schedule for 2019:
“emocha strongly supports CMS’ final rule, which modernizes Medicare reimbursement for communication technology services, especially HCPCS code G2010. This final rule will dramatically improve the way patients receive care and interact with their providers. The updates give providers the resources to use new technology to communicate with patients, assess their condition remotely, and support them throughout treatment. This will substantially benefit vulnerable patient populations and reduce the costs of healthcare.
“HCPCS code G2010 will reimburse providers for the review of photos and videos sent by patients asynchronously, also known as “store and forward” technology. This means that providers can offer established patients a modern means to communicate with their provider without an in-person appointment or the need for a live video internet connection. With code G2010, providers are required to follow-up with patients, which CMS has specified can take place via multiple channels, such as text message, chat, or phone call. With this specification, CMS encourages modern means of communication that patients are most comfortable using. G2010 evidences CMS’s recognition of the potential of asynchronous technology to provide patient-centric care at lower costs.
“We believe that there is tremendous potential to use this code to help patients who may be struggling to adhere to their treatment regimens, particularly when providers suspect that medication adherence is a challenge. emocha uses asynchronous video technology to improve medication adherence, keeping patients connected to their care teams and allowing the timely report of essential data such as symptoms or side effects.
“emocha’s mission is to empower every patient to take every dose of prescribed medication. We envision a world where taking all of your medication is a cultural norm and the consequences of nonadherence are history. Through policies such as CMS’ final rule, technology can be used to address the deadliest and most costly diseases that patients experience today.”
emocha leverages technology licensed from Johns Hopkins University that delivers video Directly Observed Therapy (DOT) to help people stay adherent to medication. Patients use a smartphone application to record videos of themselves taking each dose of medication and report any associated side effects. Providers assess patient data using a secure web portal and contact patients as needed. The platform is being used in public health departments, clinical trials, opioid use disorder treatment programs, hospitals, and managed care organizations to achieve high adherence rates and retain patients in care. Learn more at www.emocha.com.